2405 related articles for article (PubMed ID: 31561483)
1. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
2. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
3. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
4. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
5. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
6. Advancing neuro-oncology of glial tumors from big data and multidisciplinary studies.
Lin CA; Berger MS
J Neurooncol; 2020 Jan; 146(1):1-7. PubMed ID: 31853838
[TBL] [Abstract][Full Text] [Related]
7. Data analysis methods for defining biomarkers from omics data.
Li C; Gao Z; Su B; Xu G; Lin X
Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
[TBL] [Abstract][Full Text] [Related]
8. Multi-Omics Model Applied to Cancer Genetics.
Pettini F; Visibelli A; Cicaloni V; Iovinelli D; Spiga O
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072237
[TBL] [Abstract][Full Text] [Related]
9. Integrative methods for analyzing big data in precision medicine.
Gligorijević V; Malod-Dognin N; Pržulj N
Proteomics; 2016 Mar; 16(5):741-58. PubMed ID: 26677817
[TBL] [Abstract][Full Text] [Related]
10. Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.
Aleksandrova K; Egea Rodrigues C; Floegel A; Ahrens W
Curr Obes Rep; 2020 Sep; 9(3):219-230. PubMed ID: 32594318
[TBL] [Abstract][Full Text] [Related]
11. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
Umelo IA; Costanza B; Castronovo V
Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
[TBL] [Abstract][Full Text] [Related]
12. Omics Profiling in Precision Oncology.
Yu KH; Snyder M
Mol Cell Proteomics; 2016 Aug; 15(8):2525-36. PubMed ID: 27099341
[TBL] [Abstract][Full Text] [Related]
13. What did we learn from multiple omics studies in asthma?
Ivanova O; Richards LB; Vijverberg SJ; Neerincx AH; Sinha A; Sterk PJ; Maitland-van der Zee AH
Allergy; 2019 Nov; 74(11):2129-2145. PubMed ID: 31004501
[TBL] [Abstract][Full Text] [Related]
14. Using omics approaches to understand pulmonary diseases.
Kan M; Shumyatcher M; Himes BE
Respir Res; 2017 Aug; 18(1):149. PubMed ID: 28774304
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics study for interpretation of genome-wide association study.
Akiyama M
J Hum Genet; 2021 Jan; 66(1):3-10. PubMed ID: 32948838
[TBL] [Abstract][Full Text] [Related]
16. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
[TBL] [Abstract][Full Text] [Related]
17. Power of proteomics and progress in precision medicine - 13th central and eastern European proteomic conference (CEEPC), Ustroń, Poland.
Gadher SJ; Widlak P; Kovarova H
Expert Rev Proteomics; 2020 May; 17(5):335-340. PubMed ID: 32510255
[TBL] [Abstract][Full Text] [Related]
18. Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
Schena FP; Serino G; Sallustio F; Falchi M; Cox SN
Nephrol Dial Transplant; 2018 Dec; 33(12):2101-2112. PubMed ID: 29905852
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
[TBL] [Abstract][Full Text] [Related]
20. The Age of Omics-Driven Precision Medicine.
McColl ER; Asthana R; Paine MF; Piquette-Miller M
Clin Pharmacol Ther; 2019 Sep; 106(3):477-481. PubMed ID: 31407329
[No Abstract] [Full Text] [Related]
[Next] [New Search]
